General Information of the Compound
Compound ID
CP0006340
Compound Name
Dinaciclib
    Show/Hide
Synonyms
Dinaciclib
SCH 727965
SCH-727965
    Show/Hide
Structure
Formula
C21H28N6O2
Molecular Weight
396.495
Canonical SMILES
CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(nc12)N1CCCC[C@H]1CCO
    Show/Hide
InChI
InChI=1S/C21H28N6O2/c1-2-17-14-23-27-19(22-13-16-6-5-9-25(29)15-16)12-20(24-21(17)27)26-10-4-3-7-18(26)8-11-28/h5-6,9,12,14-15,18,22,28H,2-4,7-8,10-11,13H2,1H3/t18-/m0/s1
    Show/Hide
InChIKey
PIMQWRZWLQKKBJ-SFHVURJKSA-N
CAS
779353-01-4
Physicochemical Property
logP
2.2785
Rotatable Bonds
7
Heavy Atom Count
29
Polar Areas
92.63
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
7
Complexity
29

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 46926350
SID: 99431612
ChEMBL ID
CHEMBL2103840
DrugBank ID
DB12021
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05364, Heat shock factor protein 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000043 U2OS Homo sapiens (Human)  1
1
IC50 = 7 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( SCH 727965 )
Drug Name SCH 727965
Company Schering-Plough
Indication
Acute lymphoblastic leukaemia
Discontinued in Phase 3
Target(s)
Cyclin-dependent kinase 9 (CDK9)
Inhibitor
Cyclin-dependent kinase 2 (CDK2)
Inhibitor
Cyclin-dependent kinase 1 (CDK1)
Inhibitor